Medicare Part D is undergoing significant changes in 2026, most notably the implementation of a $2,000 out-of-pocket spending cap. This article explores how this critical update will reshape prescription drug costs for beneficiaries, offering insights into its impact and strategies for navigating the evolving landscape.